| 序号 | 产品名称 | 产品数量 |
| 1 | 71652-82-9 | 1 |
| 2 | Prostaglandin E2 methyl ester | 1 |
| 3 | 31753-17-0 | 1 |
| 4 | 1,3-Dioleoyl-2-Palmitoyl-rac-glycerol | 1 |
| 5 | 15(R)-Prostaglandin D2 | 1 |
| 6 | 59894-05-2 | 1 |
| 7 | 1,2-Dioleoyl-3-Docosohexaenoyl-rac-glycerol | 1 |
| 8 | 116198-39-1 | 1 |
| 9 | 1,2-Dioleoyl-sn-glycero-3-N-carboxyfluoroscein-PE | 1 |
| 10 | 11(Z)-Eicosenoic Acid methyl ester | 1 |
| 11 | 13-methyl Pentadecanoic Acid methyl ester | 1 |
| 12 | 5487-50-3 | 1 |
| 13 | 17-trifluoromethylphenyl trinor Prostaglandin F2α | 1 |
| 14 | 1-Oleoyl-2-Palmitoyl-3-Linoleoyl-rac-glycerol | 1 |
| 15 | 2534-97-6 | 1 |
| 16 | 2-AI(hydrochloride) | 1 |
| 17 | 2338-18-3 | 1 |
| 18 | 2-Amino-1-phenylbutane(hydrochloride) | 1 |
| 19 | 20735-15-3 | 1 |
| 20 | 2-methyl AP-237(hydrochloride) | 1 |
| 21 | 98608-59-4 | 1 |
| 22 | 3,4-Dimethylpyrazole(phosphate) | 1 |
| 23 | 3-thio-Pheneacrylic Acid | 1 |
| 24 | 1195-52-4 | 1 |
| 25 | Acridinium NHS ester | 1 |
| 26 | 177332-37-5 | 1 |
| 27 | C6 NBD L-threo Ceramide(d18:1/6:0) | 1 |
| 28 | 114301-95-0 | 1 |
| 29 | dinor-12-oxo Phytodienoic Acid | 1 |
| 30 | 197247-23-7 | 1 |
| 31 | N-methyl-2-AI(hydrochloride) | 1 |
| 32 | 10408-85-2 | 1 |
| 33 | Oleoyl-L-carnitine | 1 |
| 34 | pacSphingosine(d18:1) | 1 |
| 35 | 1823021-14-2 | 1 |
| 36 | Procaine(hydrochloride) | 1 |
| 37 | Prostaglandin F2αisopropyl ester | 1 |
| 38 | Sphingosine-1-phosphate(d17:1) | 1 |
| 39 | 474923-27-8 | 1 |
| 40 | &delta4-Abiraterone | 1 |
| 41 | Hydrastine((-)-β-Hydrastine) | 1 |
| 42 | Neuromuscular Disorder-Targeting Compound 1 | 1 |
| 43 | 374538-23-5 | 1 |
| 44 | Quinacrine dihydrochloride(Mepacrine dihydrochloride) | 1 |
| 45 | E3 Ligase Ligand-Linker Conjugates 24 TFA(E3 Ligase Ligand-Linker Conjugates 24 trifluoroacetate) | 1 |
| 46 | 7,4'-Di-O-methylapigenin(4',7-Dimethoxy-5-Hydroxyflavone) | 1 |
| 47 | (±)-HIP-A | 1 |
| 48 | NF-&kappaB Activation Inhibitor III | 1 |
| 49 | TAK-700 R-form | 1 |
| 50 | 752243-39-3 | 1 |
| 51 | Sodium phosphate dibasic | 1 |
| 52 | N-ethyl-4-Methoxyamphetamine(hydrochloride) | 1 |
| 53 | 93963-24-7 | 1 |
| 54 | Mca-PL | 1 |
| 55 | 140430-55-3 | 1 |
| 56 | 10(Z)-Pentadecenoic Acid | 1 |
| 57 | 84743-29-3 | 1 |
| 58 | 16-phenoxy tetranor Prostaglandin A2 | 1 |
| 59 | 51639-10-2 | 1 |
| 60 | Prostaglandin D1 | 1 |
| 61 | (±)13-HODE | 1 |
| 62 | (±)-β-Tocopherol | 1 |
| 63 | (±)5(6)-DiHET | 1 |
| 64 | 5β,6β-epoxy Cholestanol | 1 |
| 65 | 7-keto Dehydroepiandrosterone | 1 |
| 66 | 2-hydroxy Lauric Acid | 1 |
| 67 | 2984-55-6 | 1 |
| 68 | ALD-52(solution) | 1 |
| 69 | (±)-Ketoprofen Glucuronide | 1 |
| 70 | 11β-Prostaglandin F1β | 1 |
| 71 | 37785-86-7 | 1 |
| 72 | 13,14-dihydro-15-keto Prostaglandin F1α | 1 |
| 73 | 15(R)-15-methyl Prostaglandin F2α | 1 |
| 74 | 15-methyl Palmitic Acid methyl ester | 1 |
| 75 | 6929-04-0 | 1 |
| 76 | cis-8-Octadecenoic Acid | 1 |
| 77 | 5684-71-9 | 1 |
| 78 | 5-trans Fluprostenol isopropyl ester | 1 |
| 79 | (±)7(8)-DiHDPA | 1 |
| 80 | 1,2-Dioleoyl-sn-glycero-3-PG(sodium salt) | 1 |
| 81 | 67254-28-8 | 1 |
| 82 | 1,3-Distearoyl-2-Palmitoyl-rac-glycerol | 1 |
| 83 | 2190-24-1 | 1 |
| 84 | 16-phenoxy tetranor Prostaglandin F2αcyclopropyl methyl amide | 1 |
| 85 | 17-methyl Stearic Acid | 1 |
| 86 | 2724-59-6 | 1 |
| 87 | 3-Fluoroethamphetamine(hydrochloride) | 1 |
| 88 | 54982-43-3 | 1 |
| 89 | 3-keto Sphinganine(d12:0)(hydrochloride) | 1 |
| 90 | 1823032-02-5 | 1 |
| 91 | C24 Ceramide(d18:1/24:0) | 1 |
| 92 | CAY10455 | 1 |
| 93 | 290374-09-3 | 1 |
| 94 | Statine((3S,4S)-Statine) | 1 |
| 95 | E3 ligase Ligand 17 | 1 |
| 96 | 2&rdquo-O-Galloylhyperin | 1 |
| 97 | Peptone,bacteriological | 1 |
| 98 | 2',5'-dideoxy Adenosine | 1 |
| 99 | 8-iso Prostaglandin F3α | 1 |
| 100 | 7045-31-0 | 1 |
m.cnreagent.com